Syntenin-1, a syndecan-binding protein, in fact appears to be co-expressed with EGFR and to regulate its signalling in both glioblastoma [136] and urothelial cell carcinoma [136]. The gene discussed is SDCBP; the disease is transitional cell carcinoma.